跳至主要内容
临床试验/NCT04812444
NCT04812444已完成不适用

Safety and Efficacy of Peripheral Venous Stent System in the Treatment of Patients With Iliac Vein Stenosis or Occlusion: a Prospective, Multicentre, Randomized Controlled Clinical Trial.

Zhejiang Zylox Medical Device Co., Ltd.1 个研究点 分布在 1 个国家目标入组 220 人开始时间: 2020年10月9日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
220
试验地点
1
主要终点
Target vascular patency rate at 12 months after operation

研究概览

简要总结

Clinical study on safety and efficacy of Zylox peripheral venous stent system in the treatment of iliac vein stenosis or occlusion.

详细描述

The purpose of this study was to evaluate the safety and efficacy of Zylox peripheral venous stent system in the treatment of iliac vein stenosis or occlusive lesions compare with conventional venous stent.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Aged from 18 to 75 years old, male or female
  • •Subject's target lesions were stenosis and/or occlusion
  • •Subjects were able to understand the purpose of the study, demonstrate full compliance with the program and sign informed consent

排除标准

  • •Pregnant woman or who's pregnancy test is positive
  • •Lactation period woman or woman/man with fertility plan

研究组 & 干预措施

Zilver Vena Venous Stent Implantation

Active Comparator

Percutaneous stent placement in the iliofemoral veins

干预措施: Zilver Vena Venous Stent (Device)

Zylox Peripheral Venous Stent Implantation

Experimental

Percutaneous stent placement in the iliofemoral veins

干预措施: Zylox Peripheral Venous Stent (Device)

结局指标

主要结局

Target vascular patency rate at 12 months after operation

时间窗: 12 months

Target vascular patency rate

次要结局

  • Adverse Event(Preoperative、Intraoperative、up to 1 month、3 month、6 month、12 month、2 years、3 years、5 years)
  • The incidence of major adverse events(12 months)

研究者

发起方
Zhejiang Zylox Medical Device Co., Ltd.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验